ArticleCureus2025
Exploring the Relationship Between Blood Transfusions and Development of Bronchopulmonary Dysplasia in Neonates.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Plasma transfusion in neonatal sepsis.World journal of pediatrics : WJP · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTransfusions of red blood cells and platelets may worsen pulmonary inflammation and contribute to the development of bronchopulmonary dysplasia (BPD), a common lung condition in preterm infants. Although nearly all infants with severe BPD have received transfusions, their role as a potential cause of BPD has not been thoroughly studied.
objectivesThis study aimed to explore the relationship between blood product transfusions and the development of BPD among preterm neonates in the Department of Neonatology at King Fahad Medical City, Riyadh, Saudi Arabia.
methodsA retrospective study was conducted from 2011 to 2020 on neonates with a gestational age of less than 32 weeks who were admitted to the hospital within 48 hours of birth. Data were extracted from the department's medical records on patient demographics, clinical factors, and blood transfusions. Logistic regression analysis was performed to assess the relationship between blood transfusion and the development of BPD in the study cohort.
resultsA total of 1,553 neonates were included in the study. The mean gestational age was 28.8 ± 2.7 weeks, and the mean birth weight was 1264.2 ± 515.1 grams. Among the neonates, 183 (11.8%) were diagnosed with BPD. Neonates who received blood transfusions had a significantly higher likelihood of developing BPD compared to those who did not (OR = 9.1, 95% CI = 6.3-13.1), with the risk being even higher among those who received fresh frozen plasma (OR = 9.9). After adjusting for potential confounders, multivariate logistic regression analysis confirmed that blood transfusion remained a significant factor in the development of BPD (OR = 3.8, 95% CI = 2.5-5.8). Stepwise regression analysis further identified blood transfusion as the strongest predictor of BPD (OR = 4.5, 95% CI = 2.91-6.70). Additional significant predictors included retinopathy of prematurity (ROP), patent ductus arteriosus (PDA), sepsis, and non-invasive ventilation (NIV).
conclusionThis study found a significant association between blood transfusions and the development of BPD in preterm neonates, and it was found as a strong predictor. Other factors such as ROP, PDA, sepsis, and NIV use were also associated with BPD. The findings suggest that blood transfusion may play a critical role in the development of BPD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.